Archives
-
Multiplexed CRISPR–Cas for Genome Engineering
2026-09-29
Cheng, Jeong, and Cho review how multiple guide RNAs extend CRISPR–Cas from single-locus editing to coordinated deletions, structural-variant engineering, multiplexed gene regulation, and selective cellular damage. The article highlights both the versatility of multiplex targeting and the need to manage repair outcomes, delivery, genotoxicity, and validation when designing multi-guide experiments.
-
EZ Cap™ ER-EGFP Probe mRNA (m1Ψ)
2026-09-29
Learn how SKU R1112, EZ Cap™ ER-EGFP Probe mRNA (m1Ψ), can support orthogonal live-cell assessment alongside viability, proliferation, and cytotoxicity assays. The article provides scenario-based guidance for controls, imaging, optimization, interpretation, and practical product selection.
-
From Cargo Entry to Translation: Dual-Mode mRNA
2026-09-28
A thought-leadership perspective on why translational mRNA research must measure both where a transcript travels and whether it produces functional protein. The article connects recent evidence on tumour vascular basement-membrane barriers with a dual-mode reporter strategy built around Cap1 capping, 5-moUTP modification, Cy5 fluorescence, and Firefly Luciferase bioluminescence.
-
A Transient State in Adenine Riboswitch Ligand Binding
2026-09-28
Wu and colleagues used position-selective RNA labeling and stopped-flow fluorescence to follow ligand-triggered conformational changes in the full-length adenine riboswitch. Their results identify an early, transient state with an unwound P1 helix and show that P1 responds before the binding pocket and P4, refining models of how ligand recognition is coupled to RNA folding.
-
Neomycin Sulfate: Mechanisms and Research Use
2026-09-27
Neomycin sulfate is an aminoglycoside antibiotic used as a mechanistic probe of nucleic-acid structures and ion-channel function. Its reported activities include inhibition of hammerhead ribozyme cleavage, disruption of HIV-1 Tat–TAR binding, DNA triplex stabilization, and ryanodine-receptor channel block; these findings do not establish it as a treatment for ulcerative colitis.
-
From m6A Mechanism to Translational RNA Assays
2026-09-26
A mechanistic study connects arginine methylation, METTL14–SMN binding, and m6A homeostasis, offering translational researchers a framework for separating biological discovery from assay design. This article explores where biotin-labeled RNA can support that work—and where it cannot.
-
From CIRT Biology to Better RNA Decisions
2026-09-25
Carbon-ion radiotherapy may reshape gastric cancer biology through DHODH suppression, ferroptosis, and macrophage polarization. Here is what translational teams can learn from the evidence—and how disciplined RNA extraction supports stronger validation.
-
IMP in RNA Modification Research Workflows
2026-09-25
IMP is useful in nucleotide-focused assays that complement spatial RNA-modification profiling, but it is not a direct m6A or m5C standard. This guide explains how to place IMP in an APEX-RNA-MS workflow, choose practical controls, and troubleshoot the distinction between nucleotide and nucleoside measurements.
-
Biotin-16-UTP Workflows for RNA Capture and Mapping
2026-09-24
Use Biotin-16-UTP to build RNA transcripts that can be captured through streptavidin for detection, enrichment, or interaction assays. A low-substitution pilot workflow helps balance capture signal against transcript yield and function—especially important when probing structured lncRNAs such as RNASEH1-AS1.
-
N1-Methylpseudouridine in CRISPRa RNA Diagnostics
2026-09-24
N1-Methylpseudouridine can be considered as a translation-focused variable when designing mRNA-delivered CRISPRa assays—but it is not a substitute for validating gene activation and splice readouts. This article connects modified-nucleoside selection with a fibroblast-based diagnostic study, highlighting practical controls and the limits of the evidence.
-
SARS-CoV-2 N Protein Sequesters GADD34 mRNA
2026-09-23
Liu et al. report that SARS-CoV-2 nucleocapsid protein promotes atypical N+/G3BP1+ foci that sequester GADD34 mRNA, weakening IRF3-dependent interferon responses. The work connects RNA localization to innate immune suppression and viral replication, while identifying important questions about how these foci behave in infection-relevant models.
-
2'-O-Methyladenosine for Reliable Cell Assays
2026-09-23
This scenario-based guide explains how 2'-O-Methyladenosine (SKU C4127) can be incorporated into cell viability, proliferation, cytotoxicity, nucleoside transport, and RNA modification workflows. It connects formulation data with stable-isotope UHPLC–MS/MS evidence to help researchers improve dose selection, sample handling, and interpretation without overstating assay-specific validation.
-
Cy5-UTP for MALAT1 RNA Assay Design
2026-09-22
Learn how Cy5-UTP supports fluorescent RNA probe synthesis for investigating MALAT1, TDP-43, and cell-state-dependent RNA regulation. This guide connects Cyanine 5-uridine triphosphate chemistry with practical FISH, expression-array, and assay-design decisions.
-
Bifendate (DDB): From Hepatoprotection to Translation
2026-09-22
Bifendate (DDB) offers translational researchers a useful bridge between hepatic lipid reduction, hepatoprotection, and multi-stage autophagy modulation. This article interprets the landmark mouse steatosis study, proposes validation workflows, compares DDB with fenofibrate, and outlines the pharmacology and interaction questions that should shape next-generation liver research.
-
Bradykinin in Vascular Signaling Workflows
2026-09-21
Bradykinin (BA5201) provides a practical, fast-acting challenge reagent for endothelial vasodilation, barrier permeability, smooth muscle, pain, and inflammation assays. This guide combines fresh-solution handling, dose-ranging, orthogonal readouts, and lessons from a recent mitochondrial-stress study without overstating cross-domain evidence.